Navigation Links
Insulet Corporation Announces Pricing of Secondary Public Offering
Date:11/7/2007

BEDFORD, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Insulet Corporation, (Nasdaq: PODD), the manufacturer and marketer of the OmniPod(R) Insulin Management System, today announced the pricing of its public offering of 4,898,398 shares of common stock at $23.25 per share, all of which are being sold by selling stockholders. Insulet will not receive any proceeds from the sale of shares by the selling stockholders. Insulet has granted to the underwriters an option to purchase up to 734,759 shares of its common stock at the public offering price to cover any over-allotments.

J.P. Morgan Securities Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated are acting as joint book-running managers, and Leerink Swann LLC, Thomas Weisel Partners LLC and Canaccord Adams Inc. are acting as co-managers for the offering.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission and has become effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offer or sale will be made only by means of the written prospectus forming part of the effective registration statement.

A copy of the prospectus relating to the offering may be obtained by contacting one of the following:

J.P. Morgan Securities Inc., National Statement Processing, Prospectus

Library, 4 Chase Metrotech Center, CS Level, Brooklyn, NY 11245 or by

calling (718) 242-8002.

Merrill Lynch, Pierce, Fenner & Smith Incorporated, World Financial

Center, 250 Vesey Street, New York, NY 10080 or by calling (212) 449-1000.

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully- automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.

For more information about Insulet Corporation and the OmniPod System, please visit our website at http://www.insulet.com.

Contact:

Stephanie Marks for Insulet Corporation

ir@insulet.com

877-PODD-IR1 (877-763-3471)


'/>"/>
SOURCE Insulet Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program
2. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
3. Brooke Franchise Corporation Announces Selected July Results
4. MedThink Communications Retained by NanoBio Corporation
5. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
6. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
7. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
8. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
9. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
10. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
11. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... May 31, 2016 , ... Joe DiMaggio Children’s ... Florida. , The clinic is led by a world class team of ... pediatric neuropsychology and also a team of certified vestibular therapists. , The ...
(Date:5/31/2016)... ... , ... RF Safe's has decades of experience in both RF shielding design ... implicated in the most recent cell phone cancer link released by NTP researchers. , ... 26th (PDF) by the National Toxicology Program (NTP), a multiagency research effort, have ...
(Date:5/31/2016)... Overland Park, Kansas (PRWEB) , ... May 31, ... ... Kansas, announces that Keith Pardoe, FDAI, DAHC, CDC, has joined the Fire Door ... for fire door inspections and fire door and frame in-field re-labeling. He ...
(Date:5/31/2016)... Barbara, CA (PRWEB) , ... May 31, 2016 , ... Throughout the day, adults often ... for sustained motivation and awareness, but what they could be reaching for instead is a ... tea plants that are grown in Japan. This sacred tea is harvested from early June ...
(Date:5/31/2016)... ... 2016 , ... Presence Technology , a multi-channel provider ... Gartner, Inc. in the Contact Center Infrastructure Magic Quadrant (*). , Gartner’s May ... of which include: Computer-telephony integration (CTI)/Web services interfaces, Tools for integration with ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... England , May 31, 2016 , ... global demand for its Patient Status Engine wireless patient monitoring ... India , Germany , Scotland ... , The company,s 2 nd generation system, launched earlier this ... around the world , , This new technology ...
(Date:5/30/2016)... , May 30, 2016 ... "Healthcare Analytical Testing Services Market by Type (Stability, ... Services), by End User (Pharmaceutical Companies, Medical Device ... MarketsandMarkets, The market witnessed healthy growth during the ... a CAGR of 11.3% between 2016 and 2021 ...
(Date:5/30/2016)... Eye expert s ... examination before leaving hospital ... Moorfields Eye Hospital Dubai, the first overseas branch of the world-renowned ... premature babies as a special concern in the region when it ... of prematurity (ROP). ROP is a potentially blinding condition that affects ...
Breaking Medicine Technology: